Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture

Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture ID - 1314414 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -